Driving Medical Needle Free Injection Market Growth in 2025: The Role of The Increasing Number Of Diabetes Patients Is Fueling The Growth Of The Market Due To The Rising Prevalence Of Obesity And The Painless Nature Of Needle-Free Injections

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Medical Needle Free Injection Market Size Growth Forecast: What to Expect by 2025?
The market size for non-invasive medical injection has seen a brisk increase in the recent past. There is a projected increase from $14.36 billion in 2024 to $16.13 billion in 2025, reflecting a compound annual growth rate (CAGR) of 12.3%. This significant growth in the historic period can be linked to the escalating demand for painless medicinal administration, the surge in self-medication, the rise in preference for less invasive procedures, a growing inclination towards home healthcare solutions, and an increasing demand for needle-less alternatives.

How Will the Medical Needle Free Injection Market Size Evolve and Grow by 2029?
Predictions indicate a swift upswing in the medical needle free injection market in the approaching years, with an estimated worth of $25.99 billion by 2029, reflecting a compound annual growth rate (CAGR) of 12.7%. This upcoming rise during the forecast period can be accredited to the continuous development in drug delivery technology, the burgeoning requirement for personalized medication, enhanced focus on patient ease and comfort, growth in the biologics and biosimilars industry, and escalating healthcare investments within developing economies. Anticipated trends during this period involve advancement in jet injection technology, the design of more compact and mobile devices, progression in combined drug delivery systems, technological improvements in microneedle platforms for painless injections, and the development of multi-dose needle-free injectors.

View the full report here:
https://www.thebusinessresearchcompany.com/report/medical-needle-free-injection-global-market-report

What Drivers Are Propelling the Growth of Medical Needle Free Injection Market Forward?
The medical needle-free injection market is likely to expand significantly, buoyed by the rising number of diabetic patients. Diabetes, a chronic health condition characterized by the body's inability to adequately regulate blood glucose levels, is becoming more prevalent due to increasing obesity rates. This, in turn, elevates the risk of type 2 diabetes. Needle-free injections are a convenient and painless medical innovation that enable diabetic patients to administer insulin or other necessary medications via high-pressure technology. This method minimizes discomfort and sails over the hurdle of needle anxiety, leading to better patient compliance with their treatments. For example, statistics released by the UK's National Health Service in June 2024 showed that 3,615,330 individuals registered with a general practitioner were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023. This represented an 18% jump from 3,065,825 recorded cases in the previous year, underscoring the escalating number of diabetics. This, therefore, is pushing the upward trajectory of the medical needle-free injection market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24304&type=smp

What Long-Term Trends Will Define the Future of the Medical Needle Free Injection Market?
The leading players in the medical needle-free injection market are emphasizing on the development of more sophisticated products like jet-based needle-free injection systems to improve the efficacy of drug delivery and minimize discomfort for patients. These jet-based needle-free injection systems implement high-pressure liquid jet to administer medication, providing a more effective, painless alternative to regular methods. For instance, in November 2024, Sol-Millennium Medical Group, a medical device manufacturer headquartered in the US, introduced the InsuJet, a needle-free insulin injection device, in Canada. Utilizing high-pressure jet technology, this device aims to deliver insulin without needles, reducing patient discomfort, apprehension and risks associated with needles, while also enhancing treatment compliance.

What Are the Key Segments in the Medical Needle Free Injection Market?
The medical needle free injection market covered in this report is segmented -

1) By Product Type: Jet-Based Needle Free Injectors, Spring-Based Needle Free Injectors, Laser-Powered Needle Free Injectors, Vibration-Based Needle Free Injectors
2) By Mode Of Delivery: Subcutaneous Delivery, Intramuscular Delivery, Intradermal (ID) Delivery, Intravenous (IV) Delivery
3) By Application: Vaccine Delivery, Insulin Delivery, Pain Management, Oncology, Other Applications
4) By End-User: Hospitals, Clinics, Home Care Settings, Research Laboratories, Other End-Users

Subsegments:
1) By Jet-Based Needle Free Injectors: High-Pressure Jet Injectors, Disposable Jet Injectors, Multi-Use Nozzle Jet Injectors, Gas-Powered Jet Injectors, Electronically Controlled Jet Injectors
2) By Spring-Based Needle Free Injectors: Manual Spring-Loaded Injectors, Auto-Spring-Loaded Injectors, Single-Dose Spring Injectors, Reusable Spring Injectors
3) By Laser-Powered Needle Free Injectors: Infrared Laser-Based Injectors, Ultraviolet Laser-Based Injectors, Pulsed Laser Systems, Continuous Wave Laser Systems
4) By Vibration-Based Needle Free Injectors: Ultrasonic Vibration Injectors, Piezoelectric-Based Injectors, Electromagnetic Vibration Injectors, Micro-Vibration-Assisted Delivery Systems

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24304&type=smp

Who Are the Key Players Shaping the Medical Needle Free Injection Market's Competitive Landscape?
Major companies operating in the medical needle free injection market are Pfizer Inc., Medline Industries LP., Daicel Corporation, AptarGroup Inc., Gerresheimer AG, Portal Instruments, Inovio Pharmaceuticals Inc., PharmaJet Inc., RPK Group, National Medical Products Inc., Mika Medical, Injex Pharma AG, Crossject SA, InsuJet, NuGen Medical Devices Inc., Robbins Instruments, PICOCYL, MIT Canada Inc., AcuShot Needle Free, FlowBeams

What Geographic Markets Are Powering Growth in the Medical Needle Free Injection Market?
North America was the largest region in the medical needle free injection market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical needle free injection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24304

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.